"Curcumin's protective effects against Adriamycin-induced micronuclei"

| Posted in: Science

Journal name: World Journal of Pharmaceutical Research
Original article title: “protective effects of curcumin against adriamycin induced micronulei in bone marrow cells of mice.”
The WJPR includes peer-reviewed publications such as scientific research papers, reports, review articles, company news, thesis reports and case studies in areas of Biology, Pharmaceutical industries and Chemical technology while incorporating ancient fields of knowledge such combining Ayurveda with scientific data.
This page presents a generated summary with additional references; See source (below) for actual content.

Original source:

This page is merely a summary which is automatically generated hence you should visit the source to read the original article which includes the author, publication date, notes and references.

Author:

J.Karuna Kumari and K. Rudrama Devi


World Journal of Pharmaceutical Research:

(An ISO 9001:2015 Certified International Journal)

Full text available for: “protective effects of curcumin against adriamycin induced micronulei in bone marrow cells of mice.”

Source type: An International Peer Reviewed Journal for Pharmaceutical and Medical and Scientific Research

Copyright (license): WJPR: All rights reserved


Summary of article contents:

Introduction

Adriamycin, also known as doxorubicin, is a widely used anthracycline antibiotic in cancer chemotherapy. While effective in treating various malignancies, it is associated with significant side effects, including cytotoxicity and the induction of chromosomal aberrations. This research focuses on the protective potential of curcumin, a phytochemical derived from the turmeric plant (Curcuma longa), against the genotoxicity induced by Adriamycin in mouse bone marrow cells. Curcumin is recognized for its antioxidant and anticancer properties, making it a subject of interest for mitigating Adriamycin's harmful effects.

Protective Effects of Curcumin

The study evaluated the protective effects of curcumin at various doses (10, 15, and 20 mg/kg) in male Swiss albino mice exposed to Adriamycin (16 mg/kg). The results indicated that curcumin did not show mutagenic properties, implying its safety when administered alone. However, when co-administered with Adriamycin, curcumin significantly reduced the frequency of micronuclei, which are indicators of chromosomal damage in bone marrow cells. In the Adriamycin-treated group, the micronuclei frequency increased to 1.20%, while the frequency decreased to 0.78%, 0.62%, and 0.52% in the respective curcumin dose groups. This affirms the protective capacity of curcumin against Adriamycin-induced genetic damage.

Antioxidant Properties of Curcumin

Curcumin is recognized for its strong antioxidant properties. The research highlights its ability to scavenge free radicals and neutralize oxidative stress, which is a pivotal mechanism through which Adriamycin inflicts damage on normal cells. By mitigating oxidative damage, curcumin can maintain cellular integrity and potentially inhibit the DNA damage that leads to mutagenesis. These attributes position curcumin as a beneficial adjunct therapy to reduce the adverse side effects of traditional chemotherapeutic agents like Adriamycin.

The Micronucleus Test

A key methodology employed in this study was the micronucleus test, which is an effective in vivo assay used to assess the clastogenic effects of drugs. By analyzing the prevalence of micronuclei in polychromatic and normochromatic erythrocytes, researchers were able to determine the genotoxic impact of Adriamycin and the protective role of curcumin. The significant differences in micronuclei frequencies before and after curcumin treatment demonstrated its ability to counteract the genotoxicity of Adriamycin, thus reinforcing the relevance of this assay in evaluating gene protection strategies.

Conclusion

The findings of this study underscore the protective effects of curcumin against Adriamycin-induced genotoxicity in bone marrow cells of mice. Curcumin administration not only exhibited non-mutagenic characteristics but also significantly reduced the incidence of micronuclei caused by Adriamycin treatment. This suggests that curcumin could serve as a safer dietary component in chemotherapeutic regimens, offering patients a means to mitigate the harmful side effects associated with conventional cancer treatments. Further research could enhance our understanding of curcumin's therapeutic potential and its application in oncology.

FAQ section (important questions/answers):

What is the primary purpose of the study on curcumin?

The study investigates the protective effects of curcumin against adriamycin-induced genotoxicity in bone marrow cells of mice, aiming to reduce the harmful side effects of adriamycin chemotherapy.

What are the main findings regarding curcumin's effects?

Curcumin showed non-mutagenic properties and significantly reduced the incidence of micronuclei in bone marrow cells of mice treated with adriamycin, suggesting its protective effects against genotoxicity.

How was curcumin administered to the mice in the study?

Curcumin was administered in three separate doses of 10mg/kg, 15mg/kg, and 20mg/kg body weight, dissolved in distilled water, seven days prior to adriamycin administration.

What are micronuclei, and why are they significant?

Micronuclei are small nuclei that indicate chromosomal damage or defects within cells. Their presence in polychromatic erythrocytes serves as a marker of genotoxicity in the study.

What does the study suggest about curcumin as a dietary component?

The study concludes that curcumin is a safer dietary component that can potentially mitigate the genotoxic effects of chemotherapy agents like adriamycin.

What significance do the results have for cancer treatment?

These findings suggest that incorporating curcumin could improve the safety and efficacy of chemotherapy by protecting normal cells from the harmful side effects of drugs like adriamycin.

Glossary definitions and references:

Scientific and Ayurvedic Glossary list for “"Curcumin's protective effects against Adriamycin-induced micronuclei"”. This list explains important keywords that occur in this article and links it to the glossary for a better understanding of that concept in the context of Ayurveda and other topics.

1) Animal:
In the context of this study, 'animal' refers primarily to the laboratory mice used for experimental purposes. The significance of using animals, particularly male Swiss albino mice, lies in their biological similarity to humans, making them ideal subjects to assess the effects of drugs like Adriamycin and curcumin on genotoxicity and cytotoxicity.

2) Cancer:
'Cancer' denotes a group of diseases characterized by uncontrolled cell growth and proliferation. Adriamycin is frequently employed as a chemotherapeutic agent against various cancers. Understanding the protective effects of curcumin against Adriamycin-induced damage is vital for enhancing patient safety and minimizing the adverse effects of cancer treatments.

3) Table:
'Table' refers to the statistical presentations compiled in the study that summarize data regarding micronuclei incidence in bone marrow cells. Tables serve to visually organize findings, making it easier to compare different treatment groups and gauge the effectiveness of curcumin on mitigating genetic damage induced by Adriamycin.

4) Activity:
'Activity' in this context refers to the biological actions or effects exhibited by substances such as curcumin and Adriamycin. The study evaluates the protective activity of curcumin against genetic damage, clarifying its role in mitigating cellular damage and influencing the overall therapeutic efficacy of cancer treatments.

5) Water:
'Water' serves as a solvent in the preparation of curcumin extracts for the study. The extraction process employs distilled water to dissolve and concentrate curcumin from turmeric roots, enabling researchers to effectively evaluate its cytoprotective effects in vivo against Adriamycin-induced genotoxicity in mice.

6) Study (Studying):
'Study' signifies the systematic investigation conducted to assess the protective effects of curcumin on Adriamycin-induced cytogenetic damage. The research methodology, animal model, and results described in the paper reflect the rigor of scientific inquiry aiming to explore alternative cancer treatments and mitigate associated toxicities.

7) Drug:
'Drug' describes the chemical agents, such as Adriamycin and curcumin, evaluated in the research. Adriamycin is a common chemotherapeutic agent with significant side effects, while curcumin is studied for its potential protective properties against drug-induced genotoxicity, paving the way for safer cancer therapy options.

8) Toxicity:
'Toxicity' refers to the harmful effects that both Adriamycin and other chemotherapeutic agents can have on normal cells, leading to adverse outcomes during cancer treatment. The investigation into curcumin's potential to reduce toxicity is essential for improving therapeutic strategies and minimizing side effects for patients undergoing chemotherapy.

9) Nature:
'Nature' here pertains to the inherent qualities or characteristics of substances, particularly focusing on the natural origin of curcumin as a phytochemical from turmeric. The embrace of natural compounds for therapeutic purposes indicates a shift toward utilizing less toxic and more effective treatments in modern medicine.

10) Curcuma longa:
'Curcuma longa' is the scientific name for turmeric, the source of curcumin used in this study. Its significance arises from its long history in traditional medicine for various ailments, including as an antioxidant and anti-inflammatory agent, making it a valuable candidate for protecting against chemotherapeutic drug-induced damage.

11) Chemotherapy:
'Chemotherapy' denotes the treatment of cancer using chemical agents to kill or inhibit the growth of cancer cells. As the study investigates the protective role of curcumin in mitigating the genotoxic effects of Adriamycin, understanding chemotherapy's implications on both malignancies and normal cells is vital for patient care.

12) Turmeric:
'Turmeric' refers to the rhizome of Curcuma longa, which is commonly used as a spice and medicinal herb. In this research context, turmeric’s extract, rich in curcumin, serves as a potential therapeutic agent that might provide protective effects against cellular damage caused by cancer treatments employing Adriamycin.

13) Disease:
'Disease' encapsulates the conditions being treated, particularly cancer, which can significantly impact health. The relevance of studying curcumin lies in its potential to minimize the harmful effects of chemotherapy, thereby improving health outcomes and quality of life for individuals diagnosed with cancer and undergoing treatment.

14) Zoology:
'Zoology' is the branch of biology that studies animal life, which encompasses this research involving mice as experimental subjects. The study's animal model is pivotal for understanding biological responses to drugs, making zoology integral in developing safer treatment protocols based on experimental findings.

15) Diet:
'Diet' refers to the dietary intake encompassing substances such as curcumin, which may have health benefits. The study highlights the relevance of dietary components in treatment protocols, suggesting that curcumin as part of a regular diet could offer protective benefits when undergoing chemotherapy.

16) Male:
'Male' indicates the sex of the Swiss albino mice used in the study. The choice of male mice ensures uniformity in hormonal influences during the experiments, enhancing the validity and relevance of the data concerning the effects of curcumin and Adriamycin on genetic damage.

17) Antibiotic (Antibacterial):
'Antibiotic' describes a class of drugs used to treat bacterial infections. Adriamycin, while primarily an anticancer agent, belongs to the anthracycline family, with antibiotic properties as a secondary effect. Understanding its dual nature stresses the importance of assessing drugs for multiple therapeutic and side effects.

18) Karuna:
'Karuna' refers to one of the authors, J. Karuna Kumari, who contributed to the research conducted on curcumin's protective effects. Her work emphasizes collaborative scientific inquiry and the necessity of academic contributions to address complex health issues linked to cancer treatments and their side effects.

19) Kumari:
'Kumari' is part of the name of author J. Karuna Kumari, underscoring her involvement in this scientific study. The mention of her name highlights the collaborative effort within the research community to explore the potential benefits of natural compounds like curcumin in cancer therapy.

20) Killing (Killed):
'Killed' refers to the process of euthanizing the mice after conducting the experiments to collect bone marrow samples for analysis. This step is crucial for evaluating the effects of treatments on micronuclei formation and understanding the genotoxic impact of drugs in the experimental group.

21) Devi:
'Devi' refers to one of the authors, K. Rudrama Devi, indicating her contributions to the research. Acknowledging the authorship is essential in recognizing collaborative efforts in scientific inquiry aimed at understanding and addressing issues related to cancer treatment and the protective roles of natural substances.

22) New Delhi:
'New Delhi' signifies the location of the University Grants Commission, which supported the fellowship of one of the authors, facilitating the research. The acknowledgment of funding sources reflects the importance of institutional support in advancing scientific research and investigations into innovative treatment strategies.

23) Pharmacological:
'Pharmacological' relates to the study of drugs and their effects on biological systems. In this research, the pharmacological aspect of curcumin is highlighted, examining its potential as an antioxidant and protective agent in mitigating the adverse effects of chemotherapeutic drugs like Adriamycin.

24) Phytochemical:
'Phytochemical' refers to bioactive compounds derived from plants. Curcumin falls into this category and is studied for its potential health benefits, including anti-inflammatory and antioxidant properties. The investigation emphasizes the pharmacological relevance of phytochemicals in developing safer therapeutic strategies against cancer-related treatments.

25) Inflammation:
'Inflammation' denotes the body’s biological response to harmful stimuli. Curcumin is recognized for its anti-inflammatory properties, which are pivotal in cancer treatment. The research explores how curcumin can aid in reducing inflammation and tissue damage potentially caused by chemotherapeutic drugs, enhancing overall therapeutic efficacy.

26) Discussion:
'Discussion' refers to a segment in scientific articles where authors interpret and contextualize research findings. In this study, the discussion elaborates on the significance of curcumin's protective effects against Adriamycin's toxicity, linking experimental outcomes to broader implications for cancer treatment strategies and patient care.

27) Medicine:
'Medicine' encompasses the science and practice of diagnosing, treating, and preventing illness. The study investigates the potential of curcumin in enhancing cancer treatment regimens, reflecting the ongoing exploration of alternative medicine and natural products in modern therapeutic approaches.

28) Mutation:
'Mutation' indicates changes in DNA that can result from various factors, including exposure to chemotherapeutic agents like Adriamycin. Understanding how curcumin can protect against such mutations is vital for improving the safety profiles of cancer treatments and preventing long-term adverse effects associated with genetic changes.

29) Colouring (Coloring):
'Coloring' relates to one of the traditional uses of turmeric in food as a natural colorant. While the study focuses on curcumin's health benefits, the recognition of turmeric's culinary role highlights the broader appeal and multifaceted applications of this natural product beyond therapeutic contexts.

30) Methane:
'Methane' is referenced as part of the chemical properties of certain compounds. In this study, it underscores the investigation into curcumin, signaling the focus on chemical structures and their effects indicating the importance of understanding the biochemical context of natural compounds in research.

31) Maruti:
'Maruthi' refers to Prof. G. Maruthi Ram, whose contribution and facilities were significant for the research. Acknowledging his role exemplifies the collaborative nature of scientific research and emphasizes the need for institutional support in fostering investigations that seek innovative solutions to health challenges.

32) Medium:
'Medium' refers to the environment or context within which experiments are conducted. In this study, it denotes the use of various solvents and conditions necessary to extract and evaluate curcumin, emphasizing the importance of methodological rigor in ensuring valid research conclusions.

33) Powder:
'Powder' relates to the form in which turmeric and its active component, curcumin, were prepared for experimentation. The preparation of curcumin powder for extraction is essential in evaluating its bioactive properties and therapeutic potential, highlighting the importance of standardized preparations in research.

34) Delhi:
'Delhi' is the capital city of India, mentioning its significance in the context of the research collaboration and support available from local institutions. This connection underscores the collaborative efforts in scientific research that often involve regional institutional backing to promote innovative studies.

35) India:
'India' denotes the country of origin for turmeric and curcumin, reflecting the cultural and medicinal heritage surrounding these substances. The relevance of Indian traditional medicine in this study emphasizes the role of indigenous knowledge in guiding contemporary scientific research into natural therapeutic agents.

36) Food:
'Food' broadly signifies the nutrition-related aspects where turmeric is commonly included. Acknowledging curcumin's potential health benefits reinforces the idea that dietary components can play a significant role in preventive medicinal strategies, further encouraging the integration of such natural substances into diets for health improvement.

37) Cage:
'Cage' refers to the housing in which the experimental mice were kept during the study. Proper cage management ensures animal welfare and helps control environmental conditions, which is crucial for obtaining reliable experimental results and ensuring ethical standards in animal research.

Other Science Concepts:

[back to top]

Discover the significance of concepts within the article: ‘"Curcumin's protective effects against Adriamycin-induced micronuclei"’. Further sources in the context of Science might help you critically compare this page with similair documents:

Curcuma longa, Natural product, Dietary component, Antioxidant activity, Oxidative stress, Therapeutic potential, Swiss albino mice, In vitro studies, Antioxidant, Protective effect, Curcumin extract, In vivo studies, Chemical Toxicity, Free radical formation, Free Radical, Toxic side effects, Bone marrow cells, Genotoxic effect, Chromosomal aberration, Mitotic index, Phenolic compound, Micronucleus test.

Let's grow together!

I humbly request your help to keep doing what I do best: provide the world with unbiased sources, definitions and images. Your donation direclty influences the quality and quantity of knowledge, wisdom and spiritual insight the world is exposed to.

Let's make the world a better place together!

Like what you read? Consider supporting this website: